Who is at Risk for Atherosclerotic Cardiovascular Disease

Meron Mezgebe, Mercer University College of Pharmacy

Elevated cholesterol increases the risk for developing atherosclerotic cardiovascular disease (ASCVD). [1] For the monitoring of cholesterol levels the American College of Cardiology and American Heart Association (ACC/AHA) recommend an initial lipid panel of patients 21 years or older, with no clinical ASCVD, and not currently on cholesterol-lowering drugs. The ACC/AHA statin benefit group assignment is made using patients’ age, comorbidities, 10-year ASCVD risk, and lipid panel. [2] A systematic review on lipid screening of younger adults (21-39 years) found no studies directly evaluating the effects of lipid screening versus no screening in younger adults. [3] The U.S. preventative services task force (USPSTF) recommends screening for lipid disorders in men 35 years or older and women 45 years or older, unless they have increased risk of coronary heart disease. [4] Continue reading


E-Cigarettes: What Do We Really Know?

Blaire Carter, Mercer University College of Pharmacy 2015

Electronic cigarettes, commonly known as e-cigs, have become increasingly popular to adults and young people since their release in 2008. The devices are battery operated and come in a variety of flavors.1 The Centers for Disease Control and Prevention (CDC) reports that the cartridges contain nicotine, a component to produce the aerosol, and a flavoring.2  

Continue reading